Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: SynAct Pharma Receives IND Clearance From FDA

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    01/11/2022 06:20
    Nov 1 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SYNACT PHARMA RECEIVES IND CLEARANCE FROM THE FDA FOR
PHASE 2A/B
TRIAL OF AP1189 IN RA

Source text for Eikon:  ID:nMFN9M0Hwk 
Further company coverage:  SYNACT.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on SynAct Pharma AB

    See all news